APA

Moroni M., Giannetta L., Gelosa G., Secondino S., Chillura G., Colombo E. & Siena S. (20040105). Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study. : Journal of chemotherapy (Florence, Italy).

Chicago

Moroni M, Giannetta L, Gelosa G, Secondino S, Chillura G, Colombo E and Siena S. 20040105. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study. : Journal of chemotherapy (Florence, Italy).

Harvard

Moroni M., Giannetta L., Gelosa G., Secondino S., Chillura G., Colombo E. and Siena S. (20040105). Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study. : Journal of chemotherapy (Florence, Italy).

MLA

Moroni M, Giannetta L, Gelosa G, Secondino S, Chillura G, Colombo E and Siena S. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study. : Journal of chemotherapy (Florence, Italy). 20040105.